Results 111 to 120 of about 690 (120)
Some of the next articles are maybe not open access.
The AAPS Journal
Typically, parent drug is measured for bioequivalence (BE) assessment because it's more sensitive to detect formulation differences, compared to its metabolite(s). For simvastatin immediate release (IR) tablets, current product-specific guidance (PSG) recommends measuring both parent and metabolite but taking metabolite as supportive data.
Yi-Hsien Cheng +4 more
openaire +2 more sources
Typically, parent drug is measured for bioequivalence (BE) assessment because it's more sensitive to detect formulation differences, compared to its metabolite(s). For simvastatin immediate release (IR) tablets, current product-specific guidance (PSG) recommends measuring both parent and metabolite but taking metabolite as supportive data.
Yi-Hsien Cheng +4 more
openaire +2 more sources
DISOPYRAMIDE PHOSPHATE AND BASE ARE ‘VIRTUALLY BIOEQUIVALENT’
InPharma, 1978openaire +1 more source
PBPK-Based Virtual Bioequivalence Trials to Guide Drug Development
Amitava Mitra +2 moreopenaire +1 more source

